The uncertainty around tariffs and trade production measures has muted economic growth. President Trump has once again ...

A medical expert discusses how disparities in health care access affect the management and outcomes of Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer, how health ...

The Lambert Eaton Myasthenic Syndrome Market is rapidly advancing with new treatment options that are improving the lives of patients. Our newly published report, Lambert Eaton Myasthenic Syndrome ...

The FDA approved Catalyst Pharmaceuticals' supplemental New Drug Application (sNDA) for an increased daily dose of amifampridine (Firdapse) for both adults and pediatric patients with Lambert-Eaton ...

PHOENIX -- While Lambert-Eaton myasthenic syndrome (LEMS) is known to be associated with small cell lung cancer (SCLC), researchers here suggested the autoimmune disorder is underdiagnosed in the ...

“The results from the study have brought to light significant insights into the relationship between small-cell lung cancer and Lambert Eaton myasthenic syndrome, or LEMS.

The Food and Drug Administration (FDA) has expanded the approval of Firdapse ® (amifampridine) to include patients 6 years of age and older with Lambert-Eaton myasthenic syndrome (LEMS).

This study also provides a detailed overview of the opportunities along with the current trends observed in the Lambert-Eaton Myasthenic Syndrome (LEMS) Therapeutics market. With increasing cases of ...

Patients experiencing isolated dysphagia may be showing early signs of a rare condition called Lambert-Eaton myasthenic syndrome, according to a letter to the editor published on March 12 in the ...